These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1411655)

  • 1. Vascular toxicity associated with antineoplastic agents.
    Doll DC; Yarbro JW
    Semin Oncol; 1992 Oct; 19(5):580-96. PubMed ID: 1411655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular toxicity associated with antineoplastic agents.
    Doll DC; Ringenberg QS; Yarbro JW
    J Clin Oncol; 1986 Sep; 4(9):1405-17. PubMed ID: 3528405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular toxicity associated with chemotherapy for testicular cancer.
    Gerl A
    Anticancer Drugs; 1994 Dec; 5(6):607-14. PubMed ID: 7534146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular toxicity associated with chemotherapy and hormonotherapy.
    Doll DC; Yarbro JW
    Curr Opin Oncol; 1994 Jul; 6(4):345-50. PubMed ID: 7803535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombosis and anti-tumor chemotherapy].
    Barbui T; Falanga A
    Haematologica; 1991 Jun; 76 Suppl 3():276-80. PubMed ID: 1752523
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular toxicity of antineoplastic agents.
    Shahab N; Haider S; Doll DC
    Semin Oncol; 2006 Feb; 33(1):121-38. PubMed ID: 16473650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Raynaud's phenomenon and finger necrosis after treatment of ovarian seminoma with bleomycin, vinblastine and 5-fluorouracil].
    Werquin S; Kacet S; Caron J; Lacroix D; Libersa C; Coget JM; Lekieffre J
    Ann Cardiol Angeiol (Paris); 1987 Oct; 36(8):409-12. PubMed ID: 2445238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular disorders following chemotherapy].
    van der Lelie J; von dem Borne AE
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2296-9. PubMed ID: 7501060
    [No Abstract]   [Full Text] [Related]  

  • 10. Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.
    Atas E; Korkmazer N; Artik HA; Babacan O; Kesik V
    J Cancer Res Ther; 2015; 11(3):666. PubMed ID: 26458705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vascular episodes associated with therapy for carcinomas of the upper aerodigestive tract with bleomycin, vincristine, and cisplatin.
    Kukla LJ; McGuire WP; Lad T; Saltiel M
    Cancer Treat Rep; 1982 Feb; 66(2):369-70. PubMed ID: 6173125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's phenomenon after combined adjuvant chemotherapy for breast cancer.
    De Angelis R; Silveri F; Bugatti L; Filosa G
    Chemotherapy; 2003 Sep; 49(5):267-8. PubMed ID: 14504440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].
    Brouha ME; Bloemendal HJ; Kappelle LJ; Winter JB
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):457-60. PubMed ID: 12666519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil-induced Raynaud's phenomenon.
    Papamichael D; Amft N; Slevin ML; D'Cruz D
    Eur J Cancer; 1998 Nov; 34(12):1983. PubMed ID: 10023329
    [No Abstract]   [Full Text] [Related]  

  • 15. Raynaud's phenomenon following cytotoxic chemotherapy successfully managed by dorsal sympathectomy.
    MacLeod PM; Tyrrell CJ; Bliss B
    Eur J Surg Oncol; 1989 Feb; 15(1):79-81. PubMed ID: 2465189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.
    Hassan SA; Palaskas N; Kim P; Iliescu C; Lopez-Mattei J; Mouhayar E; Mougdil R; Thompson K; Banchs J; Yusuf SW
    Curr Atheroscler Rep; 2018 Feb; 20(2):10. PubMed ID: 29423705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
    Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
    Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients.
    Wingard JR; Mellits ED; Jones RJ; Beschorner WE; Sostrin MB; Burns WH; Santos GW; Saral R
    Bone Marrow Transplant; 1989 Nov; 4(6):685-9. PubMed ID: 2819287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
    Savale L; Chaumais MC; Dorfmuller P; Humbert M; Montani D
    Presse Med; 2017 Dec; 46(12 Pt 1):1223-1225. PubMed ID: 29129416
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular effects of cancer treatments.
    Campia U
    Vasc Med; 2020 Jun; 25(3):226-234. PubMed ID: 32539632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.